首页> 外文期刊>Pakistan journal of medical sciences. >The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma
【24h】

The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma

机译:小剂量泼尼松龙与普萘洛尔联用治疗小儿血管瘤的疗效

获取原文
获取外文期刊封面目录资料

摘要

Objective: To determine the outcome of combination of low dose oral Prednisolone with oral propranolol for the treatment of infantile hemangioma.Methods: The patients fulfilling the inclusion criteria were registered through outpatient department. Diagnosis was confirmed clinically and on Color Doppler ultrasonography (CD). All the patients were given oral prednisolone in a dose of 1mg/kg/day and propranolol in a dose of 0.5mg/kg/day twice a day and increased up to 1.5mg/kg/day BID within three days with close monitoring of heart rate, blood pressure and blood glucose as inpatient. Treatment was given for three months then titered down for two weeks before cessation of treatment. The follow-up of patients were performed at 7th day, at 1st month and finally at 3rd month. Treatment compliance was checked during each visit along with outcome parameters i.e. response which was excellent, good, moderate slight improvement and no effect. All the information’s were collected. Data was analyzed by using SPSS version 10.Results: Out of total 73 patients, 36.99% (n=27) were one year of age, 32.88% (n=24) were two years of age and 30.13% (n=22) were three years of age, mean±SD: 1.96±0.54 years, 53.42% (n=39) were male and 46.58% (n=34) were females, frequency of response of the treatment was recorded as 56.16% (n=41) had excellent, 23.29% (n=17) had good, 15.07% (n=11) had moderate response, 4.11% (n=3) had slight improvement and 1.37% (n=1) had no effect while frequency of acceptable outcome revealed as acceptable in 79.45% (n=58) while 20.55% (n=15) had not acceptable outcome.Conclusion: The frequency of acceptable outcome of combination of low dose oral Prednisolone with oral propranolol for the treatment of infantile hemangioma is higher.doi: http://dx.doi.org/10.12669/pjms.321.6390How to cite this:Anjum MZ, Pasha KHK, Abbas SH, Zubair M. The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma. Pak J Med Sci. 2016;32(1):211-214. doi: http://dx.doi.org/10.12669/pjms.321.6390This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:确定低剂量口服泼尼松龙与口服普萘洛尔联用治疗小儿血管瘤的疗效。方法:对符合纳入标准的患者通过门诊进行登记。临床和彩色多普勒超声(CD)均已确诊。所有患者每天两次口服口服泼尼松龙1mg / kg /天,普萘洛尔0.5mg / kg /天,三天之内BID升高至1.5mg / kg /天,并密切监测心脏住院率,血压和血糖。给予治疗三个月,然后在停止治疗前滴定两个星期。在第7天,第1个月和最后第3个月对患者进行随访。在每次就诊期间检查治疗依从性以及结果参数,即反应良好,良好,中度轻微改善且无效果。所有信息都已收集。使用SPSS 10版对数据进行分析。结果:在73名患者中,年龄为1岁的患者为36.99%(n = 27),年龄为2岁的患者为32.88%(n = 24),年龄为30.13%(n = 22)。为三岁,平均±SD:1.96±0.54岁,男性为53.42%(n = 39),女性为46.58%(n = 34),治疗的反应频率为56.16%(n = 41) )优异,23.29%(n = 17)良好,15.07%(n = 11)有中度响应,4.11%(n = 3)有轻微改善和1.37%(n = 1)没有影响,但可接受的频率结论:79.45%(n = 58)的结果为可接受,而20.55%(n = 15)的结果为不可接受。结论:低剂量口服泼尼松龙与普萘洛尔联合治疗婴儿血管瘤的可接受结果的频率较高.doi:http://dx.doi.org/10.12669/pjms.321.6390如何引用此信息:Anjum MZ,Pasha KHK,Abbas SH和ZubairM。低剂量口服泼尼松龙与普萘洛尔联用治疗结直肠癌的结果婴儿性血管瘤。朴J医学。 2016; 32(1):211-214。 doi:http://dx.doi.org/10.12669/pjms.321.6390这是根据知识共享署名许可(http://creativecommons.org/licenses/by/3.0)的条款分发的开放获取文章,只要适当引用了原始作品,便可以在任何介质中不受限制地使用,分发和复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号